Chuck Triano

Chuck Triano is Head of Investor Relations at Biogen. Mr. Triano joined Biogen in 2023, bringing more than 35 years of financial experience to the role, having held executive positions across prominent biotechnology and pharmaceutical companies over the last two decades, most recently as Chief Financial Officer for Xalud Therapeutics. Mr. Triano served as Senior Vice President of Investor Relations at Pfizer for over a decade, where he was responsible for all global investor relations functions, as well as operations planning and analysis. Previously, he led Investor Relations at Forest Laboratories, where he initiated the company’s first formal investor relations and corporate communications program. He was also a managing director at The Carson Group, a financial information organization specializing in global shareholder research and capital markets intelligence.

Mr. Triano received a bachelor’s degree from the University of Connecticut.